Cargando…
Phase II Study of Cabozantinib in Patients With Bone Metastasis
Bone metastases are often difficult to manage as they can be symptomatic and skeletal-related events (SREs) can contribute to significant morbidity and declines in performance status. We sought to identify a novel medical treatment for bone metastasis by testing the safety and efficacy of cabozantin...
Autores principales: | Choy, Edwin, Cote, Gregory M, Michaelson, M Dror, Wirth, Lori, Gainor, Justin F, Muzikansky, Alona, Sequist, Lecia V, Sullivan, Ryan J, Fidias, Panagiotis M, Shaw, Alice, Heist, Rebecca S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256024/ https://www.ncbi.nlm.nih.gov/pubmed/35524758 http://dx.doi.org/10.1093/oncolo/oyac083 |
Ejemplares similares
-
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor
por: Venkataraman, Vinayak, et al.
Publicado: (2023) -
Percutaneous Cementoplasty for the Pelvis in Bone Metastasis: 12-Year Experience
por: Park, Jong Woong, et al.
Publicado: (2021) -
Late Local Recurrence and Metastasis in Soft Tissue Sarcoma of the Extremities and Trunk Wall: Better Outcome After Treatment of Late Events Compared with Early
por: von Konow, Arvid, et al.
Publicado: (2021) -
Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
por: Verschoor, Arie Jan, et al.
Publicado: (2019) -
Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications
por: Jiang, Cindy Y, et al.
Publicado: (2022)